enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Common thyroid drug levothyroxine linked to bone mass loss - AOL

   www.aol.com/lifestyle/common-thyroid-drug...

   Researchers from Johns Hopkins University School of Medicine in Baltimore, MD, showed that total body bone mass and density both decreased in adults over the age of 65 who received levothyroxine ...

3. Levothyroxine - Wikipedia

   en.wikipedia.org/wiki/Levothyroxine

   Levothyroxine has a half-life of 7.5 days when taken daily, so about six weeks is required for it to reach a steady level in the blood. [5] Side effects from excessive doses include weight loss, trouble tolerating heat, sweating, anxiety, trouble sleeping, tremor, and fast heart rate. [5]

4. Underweight - Wikipedia

   en.wikipedia.org/wiki/Underweight

   Using the body mass index as a measure of weight-related health, with data from 2014, age-standardised global prevalence of underweight in women and men were 9.7% and 8.8%, respectively. These values were lower than what was reported for 1975 as 14.6% and 13.8%, respectively, indicating a worldwide reduction in the extent of undernutrition. [6]

5. Body fat percentage - Wikipedia

   en.wikipedia.org/wiki/Body_fat_percentage

   The body fat percentage is a measure of fitness level, since it is the only body measurement which directly calculates a person's relative body composition without regard to height or weight. The widely used body mass index (BMI) provides a measure that allows the comparison of the adiposity of individuals of different heights and weights ...

6. BMI Chart for Women of All Ages - AOL

   www.aol.com/lifestyle/bmi-chart-women-ages...

   This article features a BMI chart for women 18 and older. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Sign in. Mail. 24/7 Help. For ...

7. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   The United States Food and Drug Administration and the European Medicines Agency have approved weight loss medications for adults with either a body-mass index (BMI) of at least 30, or a body-mass index of at least 27 with at least one weight-related comorbidity. This patient population is considered to have sufficiently high baseline health ...